XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Other Comprehensive Loss
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 3 $ 97,506 $ (11) $ (64,768) $ 32,730
Balance (in Shares) at Dec. 31, 2021 32,772,060        
Stock-based compensation 715 715
Vesting of early exercised stock options 40 40
Other comprehensive loss (19) (19)
Net loss (6,932) (6,932)
Balance at Mar. 31, 2022 $ 3 98,261 (30) (71,700) 26,534
Balance (in Shares) at Mar. 31, 2022 32,772,060        
Balance at Dec. 31, 2022 $ 3 103,009 (95,097) 7,915
Balance (in Shares) at Dec. 31, 2022 33,659,460        
Stock-based compensation 724 724
Issuance of common stock upon public offering, net of issuance costs $ 1 5,179 5,179
Issuance of common stock upon public offering, net of issuance costs (in Shares) 5,340,600        
Issuance of warrants upon public offering 1,473 1,473
Issuance of common stock 2,805 2,805
Issuance of common stock (in Shares) 2,131,952        
Issuance of common stock upon exercise of options 109 109
Issuance of common stock upon exercise of options (in Shares) 245,855        
Vesting of early exercised stock options 34 34
Net loss (7,096) (7,096)
Balance at Mar. 31, 2023 $ 4 $ 113,333 $ (102,193) $ 11,144
Balance (in Shares) at Mar. 31, 2023 41,377,867